http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010038076-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57714e9a9349086c7d5e086b7db32c62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9ae63487693a84dac0e9730e0e93a33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08ad81e6123e0cc1612f675963a6808f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_671a4fd4100bda4a76373aeb81eeed55
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-07
filingDate 2009-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94678a6334cb5535bd3fb3b21d8b6fc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e0ca055c905c2c03cec8fdd8be21ea7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b074414f9b7514a8ddc7ecc3e1b071a9
publicationDate 2010-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010038076-A1
titleOfInvention Anthrax vaccine formulation and uses thereof
abstract An anthrax vaccine with alhydrogel as the adjuvant is presented in a composition formulated by mixing rPA with colloidal alhydrogel (alum) adjuvant to produce the final product, comprising 200 μg/ml rPA bound to 0.26% alhydrogel in phosphate buffered saline (PBS), said formulation containing an optimal concentration of phosphate. Methods of using the vaccines to treat or prevent infections are also presented.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9616117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014134187-A1
priorityDate 2008-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009093072-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1392
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518532

Total number of triples: 35.